With Kathy High on board, AskBio makes next leadership play and selects Bayer's Guru Ramamurthy as finance chief; Myles O'Neill and Melissa Barnes set to retire from Eli Lilly
→ The stars aligned to bring in Kathy High as president of therapeutics, and Brain Neurotherapy Bio founder Krystof Bankiewicz now leads its Parkinson’s program. And in its first big leadership move since they signed on to the team, gene therapy player AskBio has appointed Guru Ramamurthy CFO, a spokesperson tells Endpoints News. Six months removed from striking a deal to acquire AskBio, it should come as no surprise that Ramamurthy is a 20-year Bayer alum: More recently he had been the German multinational’s global finance lead for the oncology franchise, and prior to that, Ramamurthy was CFO of the North American business at Bayer Consumer Health.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters